Status:
ACTIVE_NOT_RECRUITING
Study of Interactions Between Oncologists and Resuscitators to Optimize Decision Making for Admission of Patients With Metastatic Solid Cancer to the ICU (InterOncoRea)
Lead Sponsor:
University Hospital, Brest
Conditions:
Intensive Care Unit (ICU) Patients
Metastatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of our study is to optimise the interaction between oncologists and resuscitators to improve decision-making regarding the admission of patients with metastatic solid cancers to the ICU. The ...
Detailed Description
In the vast majority of cases, there is no cure for metastatic solid cancer. As a result, the question of end of life is very often present. End of life may be linked to the aggressiveness of the dis...
Eligibility Criteria
Inclusion
- Major patient hospitalized in medical or surgical intensive care with metastatic solid cancer, whatever the primary site and whatever the reason for admission to the intensive care unit
- Start of stay in intensive care must be between June 1, 2023 and June 1, 2024.
Exclusion
- Patient objecting to data processing
- The patient is under legal protection (e.g. guardianship or curatorship)
- A patient with multiple synchronous cancers
- Diagnosis of metastatic cancer during stay in intensive care unit intensive care unit
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT06993987
Start Date
March 1 2025
End Date
October 31 2025
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Brest
Brest, France, 29200